n.a. (ASTX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

Sarissa Capital Issues Open Letter Regarding Astex Pharmaceuticals

Sarissa Capital Issues Open Letter Regarding Astex Pharmaceuticals

Sarissa Capital will not tender at current price

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Astex Pharmaceuticals, Inc. Shareholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Astex Pharmaceuticals, Inc. Shareholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Astex Pharmaceuticals, Inc.

Law Firm Brower Piven Announces Investigation Of Astex Pharmaceuticals, Inc. Proposed Acquisition

Law Firm Brower Piven Announces Investigation Of Astex Pharmaceuticals, Inc. Proposed Acquisition

The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Otsuka Pharmaceutical

Astex Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Otsuka Pharmaceutical

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating the acquisition of Astex Pharmaceuticals, Inc.

Finkelstein Thompson LLP Announces Investigation Of Astex Pharmaceuticals, Inc. Buyout

Finkelstein Thompson LLP Announces Investigation Of Astex Pharmaceuticals, Inc. Buyout

The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Astex Pharmaceuticals, Inc.

Newman Ferrara LLP Announces Investigation Of Astex Pharmaceutics, Inc.

Newman Ferrara LLP Announces Investigation Of Astex Pharmaceutics, Inc.

Newman Ferrara LLP is investigating potential claims against the board of directors of Astex Pharmaceuticals, Inc.

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Astex Pharmaceuticals (ASTX) as a pre-market mover with heavy volume candidate

Otsuka Pharmaceutical To Acquire Astex Pharmaceuticals For $8.50 Per Share In Cash

Otsuka Pharmaceutical To Acquire Astex Pharmaceuticals For $8.50 Per Share In Cash

Astex to Host Analyst/Investor Conference Call Today at 8:00 a.m. ET

Biotech Stock Mailbag: Astex Pharma, My Essential Twitter Follows

Biotech Stock Mailbag: Astex Pharma, My Essential Twitter Follows

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Astex Pharmaceuticals (ASTX) as a "perilous reversal" (up big yesterday but down big today) candidate

Astex Pharmaceuticals Announces Topline Results Of SGI-110 AML Phase 2 Study

Astex Pharmaceuticals Announces Topline Results Of SGI-110 AML Phase 2 Study

SGI-110 Phase 2 Shows Clear Activity in Patients With Acute Myeloid Leukemia

Interesting ASTX Put And Call For April 2014

Interesting ASTX Put And Call For April 2014

Investors in Astex Pharmaceuticals Inc saw new options begin trading this week, for the April 2014 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Keep these biotech stocks on your radar.